Fig. 3
From: Genetic landscape of pediatric acute myeloid leukemia in Taiwan
Kaplan–Meier estimates of 5 year event-free survival (EFS) and overall survival (OS) according to FLT3-ITD and RUNX1 mutation status (A, B) Patients with FLT3-ITD mutations showed significantly lower 5 year OS rates compared with those without the mutation (p = 0.007) and a trend toward poorer EFS (p = 0.058). (C, D) Patients with RUNX1 mutations demonstrated markedly inferior 5 year EFS and OS compared with wild-type cases (p = 0.013 and p = 0.0006, respectively). Survival curves were compared using the log-rank test.
